Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Ultimately, 678 men underwent biopsy. Gleason Grade Group 2 or higher prostate cancer was detected in 47.1% of the microultrasonography group, 42.6% of the ... negative, and 7 cases were ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly improved detection of clinically important disease. This approach caught ...

11.7% had a polygenic risk score in the 90th percentile or higher and were invited to undergo screening. Of these participants, 62.8% underwent MRI and prostate biopsy. Median age at diagnosis was 64.

Pathologists at Cookeville Regional Medical Center have become the second group in the state to fully transition to a digital ...

Biopsy with ... vast majority (92.7%) were white British, 71% had overweight or obesity, 78.6% had two or more comorbidities, 23.4% had a first-degree family history of prostate cancer, and ...

Alexander Kenigsberg, MD, discusses a new nonsurgical, robotic-focused ultrasound procedure for prostate cancer.

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

This study took a look at biopsy-naïve men from 20 centers in 8 countries with a clinical suspicion of prostate cancer based ... major complications from 7.6% to 2.2%. When they did the MRI ...

Study finds MPS2 scores are highly reproducible across DRE and non-DRE urine samples ... biomarker for prostate cancer. The test optimizes diagnostic accuracy for both biopsy naïve patients ...